MoonLake Immunotherapeutics
MLTX
#3838
Rank
C$3.61 B
Marketcap
$57.19
Share price
0.68%
Change (1 day)
-16.71%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -C$0.2 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$77.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.21 Billion164.38%
2023 -C$77.55 Million-16.81%
2022 -C$93.22 Million